Analysis of Patients Undergoing Splenectomy for Spleen Masses
Journal of Cancer and Tumor International,
Aims: Spleen masses, which are discovered on imaging studies, usually create difficulty in diagnosis and treatment. Except for lymphomas involving the spleen, primary and secondary neoplasms are rare and discovered by chance. This study analyses a series of splenectomies in a surgical clinic to evaluate the management of incidentally diagnosed splenic masses.
Study Design: This retrospective study included patients operated for spleen masses between 2010 and 2021. Patients with a history of lymphoproliferative disease and splenectomy performed as part of a larger resection were excluded.
Methodology: The patients were divided into three groups, i.e. cystic, benign and malignant, based on the results of pathological examinations. The groups were compared in terms of age, gender, tumor size, and previous history of malignancy.
Results: Splenectomy was performed in 512 patients in 11 years, 62 of whom had solid and cystic lesions detected on imaging. Thirty-five patients (56,5%) were female and the median age was 40 years (range: 18-80 years). Forty-four patients (71%) had distinct symptoms. Radiological evaluations of all the patients were made. Diagnostic biopsy could not be performed in any of the patients. The final pathological examination showed cysts in 38 patients (61,3%), benign lesions in nine patients (14,5%) and malignant lesions in 15 patients (24,2%). Out of 15 patients with malignant lesions, one patient had Hodgkin’s lymphoma, four patients had diffuse large B cell lymphoma and ten patients had metastatic tumors. There was a significant difference in age between the groups and the malignant group was older (p = 0.017). The size of the lesions also significantly differed and the malignant lesions had a significantly smaller diameter (p = 0.014). A significantly higher rate of the malignant group had a previous history of cancer (p˂0,001).
Conclusion: Spleen neoplasms are masses that are difficult to diagnose. Most of them are asymptomatic and are found after splenectomies by coincidence. Splenectomy can be utilized as both a diagnostic and curative method. It should be kept in mind that the lesions detected in the spleen in patients with a history of malignancy can be metastatic.
How to Cite
Özkök G, Argon A, Canpolat S, Taşlı F, Karahan B, Zengel B et al. Splenektomi Materyallerinin Klinikopatolojik Özellikleri: On altı Yıllık Deneyim. Okmeydanı Tıp Dergisi 2015;31(3):129-133.
Gaetke-Udager K, Wasnik AP, Kaza RK, Al-Hawary MM, Maturen KE, Udager AM, Azar SF, Francis IR. Multimodality imaging of splenic lesions and the role of non-vascular, image-guided intervention. Abdom Imaging. 2014 ;39(3):570-87.
Falk S, Krishnan J, Meis JM. Primary angiosarcoma of the spleen. A clinicopathologic study of 40 cases. Am J Surg Pathol. 1993;17(10):959-70.
Pugalenthi A, Bradley C, Gonen M, Do KG, Strong V, Jarnagin W et al. Splenectomy to treat splenic lesions: an analysis of 148 cases at a cancer center. J Surg Oncol. 2013;108(8):521-5.
Tserkezoglou A, Kontou S, Hatjieleftheriou G, Nikolaidou ME, Plataniotis G, Apostolikas N et al. Solitary parenchymal splenic recurrence of ovarian adenocarcinoma: a case report and review of the literature. Anticancer Res. 2005;25(2B):1471-6.
Fredericks C, Kubasiak J, Kumar V, Luu M. Splenectomy for Primary and Secondary Splenic Neoplasm. Am Surg. 2016;82(8):e204-5
Morgenstern L. Nonparasitic splenic cysts: pathogenesis, classification, and treatment. J Am Coll Surg. 2002;194(3):306-14.
Alkofer B, Lepennec V, Chiche L. Kystes et tumeurs spléniques: diagnostic et prise en charge [Splenic cysts and tumors: diagnosis and management]. J Chir (Paris). 2005;142(1):6-13. French.
Lam KY, Tang V. Metastatic tumors to the spleen: a 25-year clinicopathologic study. Arch Pathol Lab Med. 2000;124(4):526-30. doi: 10.5858/2000-124-0526-MTTTS.
Schön CA, Görg C, Ramaswamy A, Barth PJ. Splenic metastases in a large unselected autopsy series. Pathol Res Pract. 2006;202(5):351-6. doi: 10.1016/j.prp.2005.12.008.
Yuksel UM, Turanli S, Berberoglu AU, Gulben K. Management of Incidentally Diagnosed Splenic Masses. Indian Journal of Surgery, 2018;80(4), 318-321.
Brox A, Shustik C. Non-Hodgkin's lymphoma of the spleen. Leuk Lymphoma. 1993 ;11(3-4):165-71.
Metser U, Miller E, Kessler A, Lerman H, Lievshitz G, Oren R et al. Solid splenic masses: evaluation with 18F-FDG PET/CT. J Nucl Med. 2005;46(1):52- 9.
Kaza RK, Azar S, Al-Hawary MM, Francis IR. Primary and secondary neoplasms of the spleen. Cancer Imaging. 2010;13;10(1):173-82.
Wang TB, Hu BG, Liu DW, Gao ZH, Shi HP, Dong WG. Sclerosing angiomatoid nodular transformation of the spleen: A case report and literature review. Oncol Lett. 2016;12(2):928-932.
Malik AA, ul Bari S, Younis M, Wani KA, Rather AA. Primary splenic hydatidosis. Indian J Gastroenterol. 2011;30(4):175-7.
Thipphavong S, Duigenan S, Schindera ST, Gee MS, Philips S. Nonneoplastic, benign, and malignant splenic diseases: cross-sectional imaging findings and rare disease entities. AJR Am J Roentgenol. 2014;203(2):315-22.
Abstract View: 294 times
PDF Download: 127 times